- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Emerging Treatment Strategies for Graves’ Orbitopathy
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-18
DOI
10.1007/s40265-018-1045-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of methotrexate in thyroid-related orbitopathy
- (2018) Avi Rubinov et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial
- (2018) Rathie Rajendram et al. Lancet Diabetes & Endocrinology
- Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
- (2018) George J Kahaly et al. Lancet Diabetes & Endocrinology
- Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
- (2018) Jose V. Perez-Moreiras et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach
- (2018) Zuzana Sipkova et al. CLINICAL ENDOCRINOLOGY
- Combination Therapy of Intravenous Steroids and Orbital Irradiation is More Effective Than Intravenous Steroids Alone in Patients with Graves’ Orbitopathy
- (2017) Michael Oeverhaus et al. HORMONE AND METABOLIC RESEARCH
- Teprotumumab for Thyroid-Associated Ophthalmopathy
- (2017) Terry J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy?
- (2017) L. Bartalena et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells
- (2017) Nicholas A. J. Dawson et al. Frontiers in Immunology
- Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves’ orbitopathy
- (2016) Xiaozhen Ye et al. CLINICAL ENDOCRINOLOGY
- MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves’ orbitopathy – lessons from randomized control trials
- (2016) Marius N Stan et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
- (2016) Douglas S. Ross et al. THYROID
- Prospective, systematically recorded mycophenolate safety data in Graves’ orbitopathy
- (2016) M. Riedl et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Relation between therapy options for Graves’ disease and the course of Graves’ ophthalmopathy: a systematic review and meta-analysis
- (2016) H. X. Li et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Smoking was associated with poor response to intravenous steroids therapy in Graves’ ophthalmopathy
- (2015) Lijing Xing et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
- (2015) Marius N. Stan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
- (2015) Mario Salvi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selenium and the thyroid
- (2015) Josef Köhrle Current Opinion in Endocrinology Diabetes and Obesity
- Risk Factors for Developing Thyroid-Associated Ophthalmopathy Among Individuals With Graves Disease
- (2015) Joshua D. Stein et al. JAMA Ophthalmology
- Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy
- (2014) Guohong Gao et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Graves' Ophthalmopathy
- (2014) Wei Zhu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- B Cells from Patients with Graves' Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis
- (2014) R. S. Douglas et al. JOURNAL OF IMMUNOLOGY
- Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease
- (2014) S. Tsui et al. JOURNAL OF IMMUNOLOGY
- Treatment of Active Corticosteroid-Resistant Graves’ Orbitopathy
- (2014) Jose Vicente Pérez-Moreiras et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Adalimumab as Steroid-Sparing Treatment of Inflammatory-Stage Thyroid Eye Disease
- (2014) Reed Ayabe et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center
- (2013) M. L. Tanda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy
- (2012) L. Bartalena et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Public Health Relevance of Graves' Orbitopathy
- (2012) Katharina A. Ponto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Evaluation and Treatment of Graves Ophthalmopathy
- (2012) Marius N. Stan et al. MEDICAL CLINICS OF NORTH AMERICA
- Cohort Study on Radioactive Iodine–Induced Hypothyroidism: Implications for Graves' Ophthalmopathy and Optimal Timing for Thyroid Hormone Assessment
- (2012) Marius N. Stan et al. THYROID
- Rundle and His Curve
- (2011) George B. Bartley ARCHIVES OF OPHTHALMOLOGY
- Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease
- (2011) T. Fayers et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association
- (2011) Claudio Marcocci et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Selenium and the Course of Mild Graves' Orbitopathy
- (2011) Claudio Marcocci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
- (2011) et al. THYROID
- Graves' Ophthalmopathy
- (2010) Rebecca S. Bahn NEW ENGLAND JOURNAL OF MEDICINE
- Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy
- (2009) A K Eckstein et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Treatment Modalities for Graves’ Ophthalmopathy: Systematic Review and Metaanalysis
- (2009) Hadas Stiebel-Kalish et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Orbital Radiation for Graves Ophthalmopathy
- (2008) Elizabeth A. Bradley et al. OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started